Global Radiopharmaceutical Non-clinical CRO Service Market Growth (Status and Outlook) 2025-2031

According to this study, the global Radiopharmaceutical Non-clinical CRO Service market size will reach US$ 4626 million by 2031.

Radiopharmaceutical non-clinical CRO services refer to systematic research services including pharmacodynamics, safety, pharmacokinetics, and imaging verification provided by professional contract research organizations to pharmaceutical companies or scientific research institutions in the early stages of radiopharmaceutical research and development. This service covers key links from target verification, animal model establishment, radiolabeling, image acquisition and analysis to dose estimation, and is widely used in tumor, central nervous system, cardiovascular and other disease fields, helping the preclinical evaluation and new drug application of radiopharmaceuticals and accelerating their clinical transformation process.

United States market for Radiopharmaceutical Non-clinical CRO Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Radiopharmaceutical Non-clinical CRO Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Radiopharmaceutical Non-clinical CRO Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Radiopharmaceutical Non-clinical CRO Service players cover Charles River, Novotech, Oncodesign Services, Aixial, ABX - CRO, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Radiopharmaceutical Non-clinical CRO Service Industry Forecast” looks at past sales and reviews total world Radiopharmaceutical Non-clinical CRO Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Radiopharmaceutical Non-clinical CRO Service sales for 2025 through 2031. With Radiopharmaceutical Non-clinical CRO Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radiopharmaceutical Non-clinical CRO Service industry.

This Insight Report provides a comprehensive analysis of the global Radiopharmaceutical Non-clinical CRO Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Radiopharmaceutical Non-clinical CRO Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Radiopharmaceutical Non-clinical CRO Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radiopharmaceutical Non-clinical CRO Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radiopharmaceutical Non-clinical CRO Service.

This report presents a comprehensive overview, market shares, and growth opportunities of Radiopharmaceutical Non-clinical CRO Service market by product type, application, key players and key regions and countries.

Segmentation by Type:
Tracers
Therapeutic Radiopharmaceuticals

Segmentation by Application:
Pharmaceutical Companies
Biotech Companies
Government Agencies
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Charles River
Novotech
Oncodesign Services
Aixial
ABX - CRO
CMIC
Medpace
Minerva Imaging
Chelatec
Konica Minolta
MITRO Biotech
C-Ray
InnoStar Bio-tech

Please note: The report will take approximately 2 business days to prepare and deliver. Show more